Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer

Archives of Surgery

Volumn 134, Issue 3, 1999, Pages 245-251

  Vickers, Selwyn M ^a,b   MacMillan Crow, Lee Ann ^a   Green, Mary ^a   Ellis, Chris ^a   Thompson, John A ^a  

^a UAB Department of Surgery   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032975797     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.3.245     Document Type: Article

References (58)

1. Cameron JL, Crist OW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120-125.
2. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg. 1993;217:430-438.
3. Gonzalez AM, Buscaglia M, Ong M, et al. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol. 1990;110:753-765.
4. de longh RU, Lovicu FJ, Chamberlain CG, et al. Differential expression of fibroblast growth factor receptors during rat lens morphogenesis and growth. Invest Ophthalmol Vis Sci. 1997;38:1688-1699.
5. Wilkie AO. Craniosynostosis: genes and mechanisms. Hum Mol Genet. 1997;6: 1647-1656.
6. De Vries L, Tahiri T, Jouti N, et al. Regulation of proliferation by fibroblast growth factor in a pancreatic cancer cell line. Digestion. 1990;46:162-165.
7. Estival A, Louvel D, Coudere B, et al. Morphological and biological modifications induced in a rat pancreatic acinar cancer cell line (AR4-2J) by unscheduled expression of basic fibroblast growth factors. Cancer Res. 1993;53:1182-1187.
8. Hasegawa Y, Takada M, Yamamoto M, et al. The gradient of basic fibroblast growth factor concentration in human pancreatic cancer cell invasion. Biochem Biophys Res Commun. 1994;200:1435-1439.
9. Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res. 1993;53:5289-5296.
10. Thompson JA, Anderson KD, DiPietro JM, et al. Site-directed neovessel formation in vivo Science. 1988;241:1349-1352.
11. Thompson JA, Haudenschild CC. Anderson KD, et al. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci U S A. 1989;86:7928-7932.
12. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442-447.
13. Burgess WH. Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 1989:58:575-606.
14. Baird A. Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic factors. Curr Opin Neurobiol. 1994;4:78-86.
15. Solcia E. Capella C, Kloppel G. Tumors of the pancreas. In: Atlas of Tumor Pathology. Vol 3. Washington, DC: Armed Forces Institute of Pathology; 1995:80-81.
16. Opalenik SR, Shin JT, Wehby JN. et al. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor. J Biol Chem. 1995:270:17 457-17 468.
17. Rogelj S, Weinberg RA, Fanning P, et al. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature. 1988;331:173-175.
18. Blam SB, Mitchell R, Tischer E, et al. Addition of growth hormone secretion signal to basic fibroblast growth factor results in cell transformation and secretion of aberrant forms of the protein. Oncogene. 1988;129:136-140.
19. Forough R, Xi Z, MacPhee M, et al. Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J Biol Chem. 1993:268:2960-2968.
20. Jouanneau J, Gavrilovic J. Caruelle D, et al. Secreted or non-secreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility and invasive potential. Proc Natl Acid Sci U S A. 1991; 88:2893-2897.
21. Ornitz DM, Xu J, Colvin JS, et al. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996;271:15292-15297.
22. Jaye M, Schlessinger J, Dionne CA. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta. 1992: 1135:185-199.
23. Shin JT, Opalenik SR, Wehby JN, et al. Serum-starvation induces the extracellular appearance of FGF-1. Biochim Biophys Acta. 1996;1312:27-38.
24. Opalenik SR, Ding Q, Maller SR. et al. Glutathione depletion associated with the HIV-1 TAT protein and the extracellular appearance of FGF-1. Arch Biochem Biophys. 1998:351:17-26.
25. Jackson A, Friedman S, Zhan X, et al. Heat shock induces the release of fibroblast growth factor 1 from HIH 3T3 cells. Proc Natl Acad Sci U S A. 1992;89: 10691-10695.
26. Cendan JC, Souba WW, Copeland EM III, et al. Increased L-arginine transport in a nitric oxide-producing metastatic colon cancer cell line. Ann Surg Oncol. 1996; 3:501-508.
27. Chhatwal VJS, Ngoi SS, Chan STF, et al. Aberrant expression of nitric oxide synthase in human polyps. neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis. 1994;15:2081-2085.
28. Deliconstantinos G. Villiotou V, Stavrides JC, et al. Nitric oxide and peroxynitrite production by human erythrocytes: a causative factor of toxic anemia in breast cancer patients. Anticancer Res. 1995;15:1435-1446.
29. Farias-Eisner R, Sherman MP, Aeberhard E, et al. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc Natl Acad Sci U S A. 1994;91: 9407-9411.
30. Parkins CS. Dennis MF, Stratford MRL, et al. Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide. Cancer Res. 1995;55:6026-6029.
31. Sawyer DT. Valentine JS. How super is superoxide? Act Chem Res. 1981;14: 393-400.
32. Kerby JD, Verran D. Luo KL, et al. Immunolocalization of FGF-1 and human renal allograft vasculopathy associated with chronic rejection. Transplantation. 1996; 62:467-475.
33. Ambs S, Hussain SP, Harris CC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 1997; 11:443-448.
34. Calmels S, Hainaut P. Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res. 1997; 57:3365-3369.
35. Minor RL. Myers PR, Guerra R, et al. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109-2116.
36. Farrell AJ, Blake DR, Palmer RM, et al. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis. 1992;51:1219-1222.
37. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med. 1995;181:63-70.
38. Moncada S, Higga EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest. 1991;21:361-374.
39. Clancy RM. Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med. 1995:210:93-101.
40. Huie RE, Padmaja S. The reaction rate of nitric oxide with superoxide. Free Rad Res Commun. 1993:18:195-199.
41. Beckman JS, Ye YZ, Anderson P, et al. Extensive nitration of protein tyrosines observed in human atherosclerosis by immunohistochemistry. Biol Chem Hoppe-Seyler. 1994;375:81-88.
42. MacMillan-Crow LA, Crow JP. Kerby JD, et al. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A. 1996;93:11 853-11 858.
43. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation: nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 1994;350:9-12.
44. Brogi E, Winkles JA, Underwood R. et al. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J Clin Invest. 1993;92:2408-2418.
45. Sano H, Forough R, Maier J, et al. Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol. 1990;110:1417-1426.
46. Kerby JD, Luo KL, Ding Q, et al. Immunolocalization of acidic fibroblast growth factor and receptors in the tubointerstitial compartment of chronically rejected human renal allografts. Transplantation. 1997;63:988-995.
47. Kerby JD, Verran DJ. Luo KL, et al. Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection Transplantation. 1996:62:190-200.
48. Kerby JD. Luo KL, Ding Q, et al. Immunolocalization of acidic FGF-1 and receptors in the tubulointerstitial compartment of chronically rejected human renal allografts. Transplantation. 1997;63:988-995.
49. Imamura T. Friedman SA. Gamble S, et al. Molecular shuffling between fibroblast growth factor (FGF)-1 and FGF-2 identifies the heparin-dependence domain for FGF-1 mitogenic activity. Biochim Biophys Acta. 1995;1266:124-130.
50. Forough R, Engleka K, Thompson JA, et al. Differential expression in Escherichia coli of the alpha and beta forms of heparin-binding acidic fibroblast growth factor-1: potential role of RNA secondary structure. Biochim Biophys Acta. 1991; 1090:293-298.
51. Fitzgerald PJ, Herman L, Carol B, et al. Pancreatic acinar cell regeneration. I: cytologic, cytochemical and pancreatic weight changes. Am J Pathol. 1968;52: 983-1011.
52. Solomon TE. Regulation of exocrine pancreatic cell proliferation and enzyme synthesis. In: John LR, ed. Physiology of the Gastrointestinal Tract. New York, NY: Raven Press: 1981:837-892.
53. Loser C. Nustede R, Becker HJ. et al. Effect of neurotensin on pancreatic growth and pancreatic polyamine metabolism in rats. Int J Pancreatol. 1995:18:107-115.
54. Jouanneau J, Gavrilovic J, Caruelle D, et al. Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility and invasive potential. Proc Natl Acad Sci U S A. 1991; 88:2893-2897.
55. Tamm I, Kikuchi T, Zychlinsky A. Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c 3T3 murine fibroblasts. Proc Natl Acad Sci U S A. 1991:88:3372-3376.
56. Friess H, Korc M, Buchler MW. Molecular biology of pancreatic cancer overexpression of fibroblast growth factors. Chirurg. 1994:65:604-610.
57. Hamvas A, Palazzo R, Kaiser L. et al. Inflammation and oxygen free radical formation during pulmonary ischemia-reperfusion injury. J Appl Physiol. 1992;72: 621-628.
58. Morel D. DiCorleto P, Chisolm G. Endothelial and smooth muscle cells after low density lipoprotein in vitro for free radical oxidation. Arteriosclerosis. 1984;4: 357-364.